Table of Contents 1 Study Coverage 1.1 Retinitis Pigmentosa Treatment Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Product 1.4.2 BNP-RP 1.4.3 Cenegermin 1.4.4 CPK-850 1.4.5 Cutamesine 1.4.6 FAB-111 1.4.7 Others 1.5 Market by End User 1.5.1 Global Retinitis Pigmentosa Treatment Market Size Growth Rate by End User 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Homecare 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Retinitis Pigmentosa Treatment Market Size 2.1.1 Global Retinitis Pigmentosa Treatment Revenue 2014-2025 2.1.2 Global Retinitis Pigmentosa Treatment Sales 2014-2025 2.2 Retinitis Pigmentosa Treatment Growth Rate by Regions 2.2.1 Global Retinitis Pigmentosa Treatment Sales by Regions 2.2.2 Global Retinitis Pigmentosa Treatment Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Retinitis Pigmentosa Treatment Sales by Manufacturers 3.1.1 Retinitis Pigmentosa Treatment Sales by Manufacturers 3.1.2 Retinitis Pigmentosa Treatment Sales Market Share by Manufacturers 3.1.3 Global Retinitis Pigmentosa Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Retinitis Pigmentosa Treatment Revenue by Manufacturers 3.2.1 Retinitis Pigmentosa Treatment Revenue by Manufacturers (2014-2019) 3.2.2 Retinitis Pigmentosa Treatment Revenue Share by Manufacturers (2014-2019) 3.3 Retinitis Pigmentosa Treatment Price by Manufacturers 3.4 Retinitis Pigmentosa Treatment Manufacturing Base Distribution, Product Types 3.4.1 Retinitis Pigmentosa Treatment Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Retinitis Pigmentosa Treatment Product Type 3.4.3 Date of International Manufacturers Enter into Retinitis Pigmentosa Treatment Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Retinitis Pigmentosa Treatment Sales by Product 4.2 Global Retinitis Pigmentosa Treatment Revenue by Product 4.3 Retinitis Pigmentosa Treatment Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Retinitis Pigmentosa Treatment Breakdown Data by End User 6 North America 6.1 North America Retinitis Pigmentosa Treatment by Countries 6.1.1 North America Retinitis Pigmentosa Treatment Sales by Countries 6.1.2 North America Retinitis Pigmentosa Treatment Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Retinitis Pigmentosa Treatment by Product 6.3 North America Retinitis Pigmentosa Treatment by End User 7 Europe 7.1 Europe Retinitis Pigmentosa Treatment by Countries 7.1.1 Europe Retinitis Pigmentosa Treatment Sales by Countries 7.1.2 Europe Retinitis Pigmentosa Treatment Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Retinitis Pigmentosa Treatment by Product 7.3 Europe Retinitis Pigmentosa Treatment by End User 8 Asia Pacific 8.1 Asia Pacific Retinitis Pigmentosa Treatment by Countries 8.1.1 Asia Pacific Retinitis Pigmentosa Treatment Sales by Countries 8.1.2 Asia Pacific Retinitis Pigmentosa Treatment Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Retinitis Pigmentosa Treatment by Product 8.3 Asia Pacific Retinitis Pigmentosa Treatment by End User 9 Central & South America 9.1 Central & South America Retinitis Pigmentosa Treatment by Countries 9.1.1 Central & South America Retinitis Pigmentosa Treatment Sales by Countries 9.1.2 Central & South America Retinitis Pigmentosa Treatment Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Retinitis Pigmentosa Treatment by Product 9.3 Central & South America Retinitis Pigmentosa Treatment by End User 10 Middle East and Africa 10.1 Middle East and Africa Retinitis Pigmentosa Treatment by Countries 10.1.1 Middle East and Africa Retinitis Pigmentosa Treatment Sales by Countries 10.1.2 Middle East and Africa Retinitis Pigmentosa Treatment Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Retinitis Pigmentosa Treatment by Product 10.3 Middle East and Africa Retinitis Pigmentosa Treatment by End User 11 Company Profiles 11.1 Astellas Pharma Inc. 11.1.1 Astellas Pharma Inc. Company Details 11.1.2 Company Business Overview 11.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Products Offered 11.1.5 Astellas Pharma Inc. Recent Development 11.2 Caladrius Biosciences, Inc. 11.2.1 Caladrius Biosciences, Inc. Company Details 11.2.2 Company Business Overview 11.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Products Offered 11.2.5 Caladrius Biosciences, Inc. Recent Development 11.3 Dompe Farmaceutici S.p.A. 11.3.1 Dompe Farmaceutici S.p.A. Company Details 11.3.2 Company Business Overview 11.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Products Offered 11.3.5 Dompe Farmaceutici S.p.A. Recent Development 11.4 Genable Technologies Limited 11.4.1 Genable Technologies Limited Company Details 11.4.2 Company Business Overview 11.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Genable Technologies Limited Retinitis Pigmentosa Treatment Products Offered 11.4.5 Genable Technologies Limited Recent Development 11.5 Genethon 11.5.1 Genethon Company Details 11.5.2 Company Business Overview 11.5.3 Genethon Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Genethon Retinitis Pigmentosa Treatment Products Offered 11.5.5 Genethon Recent Development 11.6 GenSight Biologics S.A. 11.6.1 GenSight Biologics S.A. Company Details 11.6.2 Company Business Overview 11.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.6.4 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Products Offered 11.6.5 GenSight Biologics S.A. Recent Development 11.7 Grupo Ferrer Internacional, S.A. 11.7.1 Grupo Ferrer Internacional, S.A. Company Details 11.7.2 Company Business Overview 11.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Products Offered 11.7.5 Grupo Ferrer Internacional, S.A. Recent Development 11.8 ID Pharma Co., Ltd. 11.8.1 ID Pharma Co., Ltd. Company Details 11.8.2 Company Business Overview 11.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.8.4 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Products Offered 11.8.5 ID Pharma Co., Ltd. Recent Development 11.9 InFlectis BioScience 11.9.1 InFlectis BioScience Company Details 11.9.2 Company Business Overview 11.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.9.4 InFlectis BioScience Retinitis Pigmentosa Treatment Products Offered 11.9.5 InFlectis BioScience Recent Development 11.10 International Stem Cell Corporation 11.10.1 International Stem Cell Corporation Company Details 11.10.2 Company Business Overview 11.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Sales, Revenue and Gross Margin (2014-2019) 11.10.4 International Stem Cell Corporation Retinitis Pigmentosa Treatment Products Offered 11.10.5 International Stem Cell Corporation Recent Development 11.11 Ionis Pharmaceuticals, Inc. 11.12 M's Science Corporation 11.13 Mimetogen Pharmaceuticals Inc. 11.14 Nanovector s.r.l. 11.15 Orphagen Pharmaceuticals, Inc. 12 Future Forecast 12.1 Retinitis Pigmentosa Treatment Market Forecast by Regions 12.1.1 Global Retinitis Pigmentosa Treatment Sales Forecast by Regions 2019-2025 12.1.2 Global Retinitis Pigmentosa Treatment Revenue Forecast by Regions 2019-2025 12.2 Retinitis Pigmentosa Treatment Market Forecast by Product 12.2.1 Global Retinitis Pigmentosa Treatment Sales Forecast by Product 2019-2025 12.2.2 Global Retinitis Pigmentosa Treatment Revenue Forecast by Product 2019-2025 12.3 Retinitis Pigmentosa Treatment Market Forecast by End User 12.4 North America Retinitis Pigmentosa Treatment Forecast 12.5 Europe Retinitis Pigmentosa Treatment Forecast 12.6 Asia Pacific Retinitis Pigmentosa Treatment Forecast 12.7 Central & South America Retinitis Pigmentosa Treatment Forecast 12.8 Middle East and Africa Retinitis Pigmentosa Treatment Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Retinitis Pigmentosa Treatment Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Retinitis Pigmentosa Treatment Product Picture Table Retinitis Pigmentosa Treatment Market Segments Table Key Manufacturers Retinitis Pigmentosa Treatment Covered Table Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$) Figure Global Retinitis Pigmentosa Treatment Sales Market Share by Product 2014-2025 Figure BNP-RP Product Picture Table Major Manufacturers of BNP-RP Figure Cenegermin Product Picture Table Major Manufacturers of Cenegermin Figure CPK-850 Product Picture Table Major Manufacturers of CPK-850 Figure Cutamesine Product Picture Table Major Manufacturers of Cutamesine Figure FAB-111 Product Picture Table Major Manufacturers of FAB-111 Figure Others Product Picture Table Major Manufacturers of Others Table Global Retinitis Pigmentosa Treatment Market Size Growth Rate by End User 2019-2025 (K Pcs) Figure Hospital Figure Clinic Figure Homecare Figure Retinitis Pigmentosa Treatment Report Years Considered Figure Global Retinitis Pigmentosa Treatment Market Size 2014-2025 (Million US$) Figure Global Retinitis Pigmentosa Treatment Sales 2014-2025 (K Pcs) Table Global Retinitis Pigmentosa Treatment Market Size by Regions 2014-2019 (K Pcs) & (Million US$) Table Global Retinitis Pigmentosa Treatment Sales by Regions 2014-2019 (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Market Share by Regions 2014-2019 Figure Global Retinitis Pigmentosa Treatment Sales Market Share by Regions 2014-2019 Figure 2018 Global Retinitis Pigmentosa Treatment Sales Market Share by Regions Table Global Retinitis Pigmentosa Treatment Revenue by Regions 2014-2019 (Million US$) Table Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions 2014-2019 Figure Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions 2014-2019 Figure 2018 Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions Table Global Retinitis Pigmentosa Treatment Sales by Manufacturers (2014-2019) (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Share by Manufacturers (2014-2019) Figure Global Retinitis Pigmentosa Treatment Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Retinitis Pigmentosa Treatment Revenue by Manufacturers (2014-2019) (Million USD) Table Retinitis Pigmentosa Treatment Revenue Share by Manufacturers (2014-2019) Figure Retinitis Pigmentosa Treatment Value Share by Manufacturers in 2018 Table Key Manufacturers Retinitis Pigmentosa Treatment Price (2014-2019) (USD/Pcs) Table Retinitis Pigmentosa Treatment Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Retinitis Pigmentosa Treatment Product Type Table Date of International Manufacturers Enter into Retinitis Pigmentosa Treatment Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Share by Product (2014-2019) Figure Global Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure Global Retinitis Pigmentosa Treatment Sales Market Share by Product in 2018 Table Global Retinitis Pigmentosa Treatment Revenue by Product (2014-2019) (Million US$) Table Global Retinitis Pigmentosa Treatment Revenue Share by Product (2014-2019) Figure Global Retinitis Pigmentosa Treatment Revenue Market Share by Product (2014-2019) Figure Global Retinitis Pigmentosa Treatment Revenue Market Share by Product in 2018 Table Retinitis Pigmentosa Treatment Price by Product 2014-2019 (USD/Pcs) Table Global Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Share by End User (2014-2019) Figure Global Sales Retinitis Pigmentosa Treatment Market Share by End User (2014-2019) Figure Global Sales Retinitis Pigmentosa Treatment Market Share by End User in 2018 Figure North America Retinitis Pigmentosa Treatment Sales Growth Rate 2014-2019 (K Pcs) Figure North America Retinitis Pigmentosa Treatment Revenue Growth Rate 2014-2019 (Million US$) Table North America Retinitis Pigmentosa Treatment Sales by Countries (2014-2019) (K Pcs) Table North America Retinitis Pigmentosa Treatment Sales Market Share by Countries (2014-2019) Figure 2018 North America Retinitis Pigmentosa Treatment Sales Market Share by Countries Table North America Retinitis Pigmentosa Treatment Revenue by Countries (2014-2019) (Million US$) Table North America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 North America Retinitis Pigmentosa Treatment Revenue Market Share by Countries Figure United States Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure United States Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (K Pcs) Figure Canada Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Canada Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Mexico Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Table North America Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table North America Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure 2018 North America Retinitis Pigmentosa Treatment Market Share by Product Table North America Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table North America Retinitis Pigmentosa Treatment Sales Market Share by End User (2014-2019) Figure 2018 North America Retinitis Pigmentosa Treatment Market Share by End User Figure Europe Retinitis Pigmentosa Treatment Sales Growth Rate 2014-2019 (K Pcs) Figure Europe Retinitis Pigmentosa Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Europe Retinitis Pigmentosa Treatment Sales by Countries (2014-2019) (K Pcs) Table Europe Retinitis Pigmentosa Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Europe Retinitis Pigmentosa Treatment Sales Market Share by Countries Table Europe Retinitis Pigmentosa Treatment Revenue by Countries (2014-2019) (Million US$) Table Europe Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Retinitis Pigmentosa Treatment Revenue Market Share by Countries Figure Germany Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Germany Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure France Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure France Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure UK Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure UK Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Italy Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Russia Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Europe Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table Europe Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure 2018 Europe Retinitis Pigmentosa Treatment Market Share by Product Table Europe Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table Europe Retinitis Pigmentosa Treatment Sales Market Share by End User (2014-2019) Figure 2018 Europe Retinitis Pigmentosa Treatment Market Share by End User Figure Asia Pacific Retinitis Pigmentosa Treatment Sales Growth Rate 2014-2019 (K Pcs) Figure Asia Pacific Retinitis Pigmentosa Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Retinitis Pigmentosa Treatment Sales by Countries (2014-2019) (K Pcs) Table Asia Pacific Retinitis Pigmentosa Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Retinitis Pigmentosa Treatment Sales Market Share by Countries Table Asia Pacific Retinitis Pigmentosa Treatment Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Countries Figure China Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure China Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Japan Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Korea Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure India Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure India Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Australia Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Indonesia Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Malaysia Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Philippines Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Thailand Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Vietnam Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Singapore Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table Asia Pacific Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Retinitis Pigmentosa Treatment Market Share by Product Table Asia Pacific Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table Asia Pacific Retinitis Pigmentosa Treatment Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Retinitis Pigmentosa Treatment Market Share by End User Figure Central & South America Retinitis Pigmentosa Treatment Sales Growth Rate 2014-2019 (K Pcs) Figure Central & South America Retinitis Pigmentosa Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Retinitis Pigmentosa Treatment Sales by Countries (2014-2019) (K Pcs) Table Central & South America Retinitis Pigmentosa Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Retinitis Pigmentosa Treatment Sales Market Share by Countries Table Central & South America Retinitis Pigmentosa Treatment Revenue by Countries (2014-2019) (Million US$) Table Central & South America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Retinitis Pigmentosa Treatment Revenue Market Share by Countries Figure Brazil Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Brazil Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Argentina Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table Central & South America Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Retinitis Pigmentosa Treatment Market Share by Product Table Central & South America Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table Central & South America Retinitis Pigmentosa Treatment Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Retinitis Pigmentosa Treatment Market Share by End User Figure Middle East and Africa Retinitis Pigmentosa Treatment Sales Growth Rate 2014-2019 (K Pcs) Figure Middle East and Africa Retinitis Pigmentosa Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Retinitis Pigmentosa Treatment Sales by Countries (2014-2019) (K Pcs) Table Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Countries Table Middle East and Africa Retinitis Pigmentosa Treatment Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Countries Figure GCC Countries Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure GCC Countries Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Turkey Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure Egypt Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Retinitis Pigmentosa Treatment Sales Growth Rate (2014-2019) (K Pcs) Figure South Africa Retinitis Pigmentosa Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Retinitis Pigmentosa Treatment Sales by Product (2014-2019) (K Pcs) Table Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Retinitis Pigmentosa Treatment Market Share by Product Table Middle East and Africa Retinitis Pigmentosa Treatment Sales by End User (2014-2019) (K Pcs) Table Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Retinitis Pigmentosa Treatment Market Share by End User Table Astellas Pharma Inc. Company Details Table Astellas Pharma Inc. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Astellas Pharma Inc. Recent Development Table Caladrius Biosciences, Inc. Company Details Table Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Caladrius Biosciences, Inc. Recent Development Table Dompe Farmaceutici S.p.A. Company Details Table Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Dompe Farmaceutici S.p.A. Recent Development Table Genable Technologies Limited Company Details Table Genable Technologies Limited Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Genable Technologies Limited Recent Development Table Genethon Company Details Table Genethon Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Genethon Recent Development Table GenSight Biologics S.A. Company Details Table GenSight Biologics S.A. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table GenSight Biologics S.A. Recent Development Table Grupo Ferrer Internacional, S.A. Company Details Table Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table Grupo Ferrer Internacional, S.A. Recent Development Table ID Pharma Co., Ltd. Company Details Table ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table ID Pharma Co., Ltd. Recent Development Table InFlectis BioScience Company Details Table InFlectis BioScience Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table InFlectis BioScience Recent Development Table International Stem Cell Corporation Company Details Table International Stem Cell Corporation Retinitis Pigmentosa Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019) Table International Stem Cell Corporation Recent Development Table Ionis Pharmaceuticals, Inc. Company Details Table M's Science Corporation Company Details Table Mimetogen Pharmaceuticals Inc. Company Details Table Nanovector s.r.l. Company Details Table Orphagen Pharmaceuticals, Inc. Company Details Table Global Retinitis Pigmentosa Treatment Sales Forecast by Regions 2019-2025 (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Market Share Forecast by Regions 2019-2025 Table Global Retinitis Pigmentosa Treatment Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Retinitis Pigmentosa Treatment Revenue Market Share Forecast by Regions 2019-2025 Table Global Retinitis Pigmentosa Treatment Sales Forecast by Product 2019-2025 (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Market Share Forecast by Product 2019-2025 Table Global Retinitis Pigmentosa Treatment Revenue Forecast by Product 2019-2025 (Million US$) Table Global Retinitis Pigmentosa Treatment Revenue Market Share Forecast by Product 2019-2025 Table Global Retinitis Pigmentosa Treatment Sales Forecast by End User 2019-2025 (K Pcs) Table Global Retinitis Pigmentosa Treatment Sales Market Share Forecast by End User 2019-2025 Figure North America Retinitis Pigmentosa Treatment Sales Growth Rate Forecast (2019-2025) (K Pcs) Figure North America Retinitis Pigmentosa Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Retinitis Pigmentosa Treatment Sales Growth Rate Forecast (2019-2025) (K Pcs) Figure Europe Retinitis Pigmentosa Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Retinitis Pigmentosa Treatment Sales Growth Rate Forecast (2019-2025) (K Pcs) Figure Asia Pacific Retinitis Pigmentosa Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Retinitis Pigmentosa Treatment Sales Growth Rate Forecast (2019-2025) (K Pcs) Figure Central & South America Retinitis Pigmentosa Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Retinitis Pigmentosa Treatment Sales Growth Rate Forecast (2019-2025) (K Pcs) Figure Middle East and Africa Retinitis Pigmentosa Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Retinitis Pigmentosa Treatment Value Chain Table Retinitis Pigmentosa Treatment Customers List Table Retinitis Pigmentosa Treatment Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Astellas Pharma Inc. Caladrius Biosciences, Inc. Dompe Farmaceutici S.p.A. Genable Technologies Limited Genethon GenSight Biologics S.A. Grupo Ferrer Internacional, S.A. ID Pharma Co., Ltd. InFlectis BioScience International Stem Cell Corporation Ionis Pharmaceuticals, Inc. M's Science Corporation Mimetogen Pharmaceuticals Inc. Nanovector s.r.l. Orphagen Pharmaceuticals, Inc.